InvestSMART

Colonial Select Personal Superannuation - Colonial Wholesale Global Health & Biotech - Managed Fund (Closed)

Fund Objective
To provide long-term capital growth.
Fund Strategy
Invests in listed companies around the world, whose primary business is in the field of pharmaceuticals, biotechnology, medical devices or medical services. Shares are held in at least 25 companies. No more than 5% of the value of the option is held in companies with a market value less than US$250 million. No more than 10% of the value of the option is held in any one company. Asset allocation ranges (with benchmarks in brackets): international equities 80-100% (100%) and cash 0-20% (0%).

Fund Performance Comparison

Relative Fund Performance vs {{ fund.benchmark.peers.peerCount }} peers using {{ fund.benchmark.name }} as their benchmark.

{{ fund.name }}
Peers
Benchmark ({{ fund.benchmark.name }})
{{ fund.model.name }}
The performance of the peers is calculated as the total of the performance for each time period for all the funds in the peer group, divided by the number of funds in the peer group.
grow your money
Grow your money, not your fees
It's fees rather than returns that make the biggest difference to your investment's compounding returns.
Free Fees Report
investing
Investing made simple
Our professionally-tailored investment portfolios consistently beat most of our peers.
Free investor guide
Grow your money, not your fees
It's fees rather than returns that make the biggest difference to your investment's compounding returns. Free Fees Report
Investing made simple
Our professionally-tailored investment portfolios consistently beat most of our peers. Free investor guide

Fees Comparison

{{ fund.mer | number:2 }}
% p.a.
{{ fund.name }}
{{ modelPortfolio.mer * 100 | number:2 }}
% p.a.
{{ modelPortfolio.name }}
{{ fund.benchmark.peers.mer * 100 | number:2 }}
% p.a.
Average of peers ({{ fund.benchmark.peers.peerCount }})
NOTE: Fee data has been provided by Morningstar, it may not include all costs being charged on your investment such as platform and adviser fees. You should check your fund manager or adviser statements to find out the exact fees you are being charged. Peers are funds that use the same benchmark in the Morningstar database.
Upsell Banner

Fund performance

  1M 3M 6M 1Y p.a. 2Y p.a. 3Y p.a. 5Y p.a. 10Y p.a.
Total return 5.2% 3% 5.09% 3.74% 12.37% 12.19% 12.21% 17.96%
Growth return 2.79% 0.06% -0.89% 5.23% 8.5% 11.15% 12.26% 17.45%
Income return 2.41% 2.94% 5.98% -1.49% 3.87% 1.04% -0.05% 0.51%
Market index (MSCI World Ex Australia NR AUD)
Total return 3.02% 14.06% 20.11% 28.72% 15.87% 14.43% -% 13.43%
As at 30 Apr 2021. Returns for periods greater than 1 year are annualised. All figures are percentages.

Asset Allocation

Colonial Select Personal Superannuation - Colonial Wholesale Global Health & Biotech
International Equities
97.20%
Cash
2.80%
Australian Equities
0%
Property
0%
Fixed Interest
0%
Alternatives
0%
Average Allocation of Peers
International Equities
92.32%
Cash
3.56%
Australian Equities
2.34%
Property
1.76%
Fixed Interest
-0.04%
Alternatives
0.06%

General Information

Fund Details
Type Description
Colonial Select Personal Superannuation - Colonial Wholesale Global Health & Biotech
Closed
Colonial Mutual Superannuation Pty Ltd
PRU0384AU
Equity World Other
Not Rated
Superannuation Fund
1 Sep 2001
$0 million (as at 30 Apr 2021)
n/a
$35.9878 (as at 21 May 2021)
Finalised
Offer information
Type Description
Standard entry fee 4%
Indirect Cost Ratio (ICR) 0.99% (as at 30 Jun 2011)
Minimum initial investment $1,500.00
Minimum additional investments $500.00
Minimum redemption amount

FAQs about the Colonial Select Personal Superannuation - Colonial Wholesale Global Health & Biotech

The objective of the Colonial Select Personal Superannuation - Colonial Wholesale Global Health & Biotech managed fund is To provide long-term capital growth.

The strategy of the Colonial Select Personal Superannuation - Colonial Wholesale Global Health & Biotech managed fund is Invests in listed companies around the world, whose primary business is in the field of pharmaceuticals, biotechnology, medical devices or medical services. Shares are held in at least 25 companies. No more than 5% of the value of the option is held in companies with a market value less than US$250 million. No more than 10% of the value of the option is held in any one company. Asset allocation ranges (with benchmarks in brackets): international equities 80-100% (100%) and cash 0-20% (0%).

The APIR code of the Colonial Select Personal Superannuation - Colonial Wholesale Global Health & Biotech managed fund is PRU0384AU.

Colonial Select Personal Superannuation - Colonial Wholesale Global Health & Biotech’s total return last month was 5.2%. This was made up of a growth return of 2.79% and an income return of 2.41%. These returns were calculated as at 30 Apr 2021.

Colonial Select Personal Superannuation - Colonial Wholesale Global Health & Biotech’s total return for the last three months was 3%. This was made up of a growth return of 0.06% and an income return of 2.94%%. These returns were calculated as at 30 Apr 2021.

Colonial Select Personal Superannuation - Colonial Wholesale Global Health & Biotech’s one-year total return is 3.74%. This was made up of a growth return of 5.23% and an income return of -1.49%. These returns were calculated as at 30 Apr 2021.

Colonial Select Personal Superannuation - Colonial Wholesale Global Health & Biotech’s one-year total return is 12.19%. This was made up of a growth return of 11.15% and an income return of 1.04%. These returns were calculated as at 30 Apr 2021.

The asset allocation of the Colonial Select Personal Superannuation - Colonial Wholesale Global Health & Biotech managed fund is :

International Equities
97.20%
Cash
2.80%
Australian Equities
0%
Property
0%
Fixed Interest
0%
Alternatives
0%

The Responsible Entity for the Colonial Select Personal Superannuation - Colonial Wholesale Global Health & Biotech managed fund is Colonial Mutual Superannuation Pty Ltd.

The Colonial Select Personal Superannuation - Colonial Wholesale Global Health & Biotech managed fund belongs to the Equity World Other sector/asset class.

As at 30 Apr 2021, the size of the Colonial Select Personal Superannuation - Colonial Wholesale Global Health & Biotech managed fund was $0 million.

The Colonial Select Personal Superannuation - Colonial Wholesale Global Health & Biotech managed fund has an inception date of 1 Sep 2001.

The current entry price of the Colonial Select Personal Superannuation - Colonial Wholesale Global Health & Biotech managed fund is $ per unit and the current exit price is $35.9878 per unit (as at 21 May 2021).

The current exit price of the Colonial Select Personal Superannuation - Colonial Wholesale Global Health & Biotech managed fund is $35.9878 per unit and the current entry price is $ per unit (as at 21 May 2021).

The minimum initial investment amount for the Colonial Select Personal Superannuation - Colonial Wholesale Global Health & Biotech managed fund is $1,500. Minimum additional investment is $500.

Fund data sourced from Morningstar. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only. Whilst every care has been taken in producing these numbers, neither Morningstar nor InvestSMART can make any guarantees around the complete accuracy of these figures. Should you decide to change investments, please read all relevant disclosure documents including the Product Disclosure Statements and if required, you may consider speaking to a financial professional for further guidance. A tax event may be realised as a result of switching investments. Past performance is not a reliable indicator of future performance.